
Progress in Medicinal Chemistry
Description
Key Features
*Publishes on an annual basis to bring you the most innovative updates in medicinal chemistry
*Available as an online resource via ScienceDirect
Readership
Table of Contents
- Preface
List of Contributors
Hit and Lead Identification: Efficient practices for drug discovery
DPPIV Inhibition: Promising Therapy for the Treatment of Type 2 Diabetes
Recent Progress Towards Nonpeptide Ligands for the Melanocortin-4 Receptor
Tuberculosis chemotherapy: recent developments and future perspectives
Subject Index
Author Index (Volumes 1-45)
Subject Index (Volumes 1-45)
Product details
- No. of pages: 232
- Language: English
- Copyright: © Elsevier Science 2007
- Published: February 19, 2007
- Imprint: Elsevier Science
- eBook ISBN: 9780080471310
- Hardcover ISBN: 9780444528087
About the Editors
F.D. King
Affiliations and Expertise
G. Lawton

From 2003 to 2007 he was founding Research Director with Lectus Therapeutics building from start-up a drug discovery organisation; generating the team, facilities and project portfolio targeting the next generation of ion channel modulating medicines.
Since 2001 Geoff has provided scientific and strategic evaluation and advice on drug discovery as an independent consultant for a number small and medium sized biotech companies, CROs, VCs, academic groups and medical research charities.
Geoff serves on the Board of Antabio, a French biotech company developing tomorrow’s antibacterial drugs.
He is a founder of INMedD, a new medicines discovery social enterprise.
Affiliations and Expertise
Ratings and Reviews
There are currently no reviews for "Progress in Medicinal Chemistry"